title: [Remission under treatment of cutaneous xanthomatosis disclosing myeloma: apropos of a case with a three-year course].
abstract: We report a case of IgG lambda multiple myeloma with inaugural cutaneous xanthomatosis. A three years follow up showed parallel evolution of xanthomatosis and monoclonal gammapathy during therapy suggesting that the association is not coincidental. A decrease in IDL catabolism could be responsible. The monoclonal gammapathy could react with IDL and disturb the recognition of apolipoprotein E by its hepatic receptor.
authors.affiliation: Service de Médecine Interne, Hôpital de Boisguillaume, Boisguillaume.
authors.forename: A
authors.initials: A
authors.lastname: Gancel
authors.forename: H
authors.initials: H
authors.lastname: Lévesque
authors.forename: P
authors.initials: P
authors.lastname: Mabilais
authors.forename: A
authors.initials: A
authors.lastname: Daragon
authors.forename: H
authors.initials: H
authors.lastname: Courtois
mesh_terms: D003520:Cyclophosphamide / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008875:Middle Aged; D009101:Multiple Myeloma / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy; D010265:Paraproteinemias / Q000150:complications; D011241:Prednisone / Q000627:therapeutic use; D012871:Skin Diseases / Q000175:diagnosis / Q000209:etiology; D013997:Time Factors; D014973:Xanthomatosis / Q000175:diagnosis / Q000209:etiology*
chemical_list: D003520:Cyclophosphamide; D011241:Prednisone
vernacular_title: Régression sous traitement d'une xanthomatose cutanée révélatrice d'un myélome: à propos d'un cas avec 3 ans d'évolution.